Hebei Changshan Biochemical Pharmaceutical Co., Ltd. announces its Heparin Sodium Injection has been selected for the 12th batch of national centralized drug procurement. This product generated ¥119.94 million in sales in 2025, representing 13.71% of total revenue. The procurement period is from the effective date to December 31, 2029.
Summary generated by AI · Always verify with source document
Stock Code: 300255 Stock Abbreviation: Changshan Pharmaceutical Announcement Number: 2026-28
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
Announcement on Company Products Being Selected for the 12th Batch of National Centralized Drug Procurement
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.